Anebulo Pharmaceuticals Inc (ANEB)
0.5700 x 1 1.6800 x 2
Post-market by (Cboe BZX)
1.0200 -0.0600 (-5.56%) 04/04/25 [NASDAQ]
0.5700 x 1 1.6800 x 2
Post-market 1.0200 unch (unch) 16:00 ET
for Fri, Apr 4th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2024 | 06-2023 | 06-2022 | 06-2021 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,202 | -11,732 | -6,826 | -30,253 | -175 |
| Depreciation Amortization | 151 | N/A | N/A | N/A | N/A |
| Accounts receivable | N/A | N/A | N/A | 4 | N/A |
| Accounts payable and accrued liabilities | -378 | 154 | 271 | 110 | N/A |
| Other Working Capital | -799 | 1,165 | 908 | -1,445 | 23 |
| Other Operating Activity | 1,137 | 731 | 210 | 26,713 | 1 |
| Operating Cash Flow | $-8,091 | $-9,683 | $-5,437 | $-4,871 | $-151 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 200 |
| Debt Repayment | N/A | N/A | N/A | -201 | N/A |
| Common Stock Issued | N/A | 6,699 | N/A | 20,605 | N/A |
| Other Financing Activity | -62 | -317 | 0 | 1,428 | 2,976 |
| Financing Cash Flow | $-62 | $6,382 | $N/A | $21,832 | $3,176 |
| Beginning Cash Position | 11,247 | 14,549 | 19,986 | 3,025 | N/A |
| End Cash Position | 3,094 | 11,247 | 14,549 | 19,986 | 3,025 |
| Net Cash Flow | $-8,153 | $-3,301 | $-5,437 | $16,961 | $3,025 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,091 | -9,683 | -5,437 | -4,871 | -151 |
| Free Cash Flow | -8,091 | -9,683 | -5,437 | -4,871 | -151 |